[MO30] Mini-Oral Session 30　Hematologic Malignancies
【E】

[MO30-2] WT1 mRNA expression level is a potentially useful marker for the monitoring of MRD in pediatric patients with ALL

^○Yoshiko Hashii^1,7, Keizo Horibe^2,7, Yuka Iijima^2,7, Tatsutoshi Nakahata^3,7, Keiko Yagi^4,7, Hara Jyunichi^5,7, Toshihiko Imamura^6,7 (1.Department of Pediatrics, Osaka International Cancer Institute, 2.Clinical Research Center, National Hospital Organization Nagoya Medical Center, 3.Center for iPS Cell Research and Application, Kyoto University, 4.Yumura Clinic, 5.Department of Pediatric Hematology and Oncology, Osaka City General Hospital, 6.Department of Pediatrics, Kyoto Prefectural University of Medicine, 7.Japan Association of Childhood Leukemia Study)